Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06525220
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab Vs Pembrolizumab in First-line Treatment of Head and Neck Cancer
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: